Table 4.
Prevalence of individual metabolic syndrome abnormalities in pregnant women with metabolic syndrome according to four definitions
| Components of MetS | NCEPT–ATP III [5] N = 197 |
JIS MetS Criteria [6] N = 247 |
NCEPT–ATP III Bartha [10] modification N = 12 | NHLBI/AHA Chatzi [8, 9] modification N = 85 |
||||
|---|---|---|---|---|---|---|---|---|
| Increased fasting glycemia | ≥110 mg/dl | 44 (22.3) | ≥100 mg/dl | 89 (36.0) | ≥105 mg/dl | 10 (83.3) | ≥100 mg/dl | 40 (47.1) |
| Obesity | ||||||||
| BMI | >30 kg/m2 | 11 (91.7) | >30 kg/m2 | 40 (47.1) | ||||
| Waist circumference | >88 cm | 189 (95.9) | ≥80 cm | 246 (99.6) | – | – | ||
| Hypertriglyceridemia | ≥150 mg/dl | 166 (84.3) | ≥150 mg/dl | 199 (80.6) | ≥270 mg/dl | 1 (8.3) | ≥150 mg/dl | 78 (91.8) |
| Decreased HDL-C | <50 mg/dl | 45 (22.8) | <50 mg/dl | 49 (19.8) | <40 mg/dl | 2 (16.7) | <50 mg/dl | 32 (37.6) |
| Hypertension | ≥130/85 mm/Hg | 179 (90.9) | ≥130/85 mm/Hg | 216 (87.4) | ≥130/85 mm/Hg | 12 (100) | ≥130/85 mm/Hg | 79 (92.9) |
| Metabolic syndrome % | 29.2 (a) | 36.6 (b) | 1.8 (c) | 12.6 (d) | ||||